Literature DB >> 5706088

[Antidotal therapy in alkylphosphate poisoning].

W D Erdmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5706088

Source DB:  PubMed          Journal:  Arch Toxikol        ISSN： 0003-9446


× No keyword cloud information.
  10 in total

1.  COMPARISONS OF REACTIVATION AND AGING RATES OF EEL ACETYLCHOLINESTERASE INHIBITED BY GB AND 4-PPAM.

Authors:  J C LAMB; G M STEINBERG
Journal:  Biochim Biophys Acta       Date:  1964-07-08

2.  A powerful reactivator of alkylphosphate-inhibited acetylcholinesterase.

Authors:  I B WILSON; B GINSBURG
Journal:  Biochim Biophys Acta       Date:  1955-09

3.  [Organ parenchymal damage in E 605 poisoning].

Authors:  J TRAUB
Journal:  Arch Toxikol       Date:  1955

4.  [Occupational poisonings by phosphorus compounds (phosphorus chloride, phosphine, and organic phosphates].

Authors:  W REINL
Journal:  Arch Toxikol       Date:  1956

5.  [Poisoning with E 605 (O, O-diethyl-O-p-nitrophenyl thiophosphoric acid ester); collective report on fatal cases published up to January 1, 1955 and 10 personal cases as well as theoretical bases of poisoning and detection methods].

Authors:  O PRIBILLA
Journal:  Arch Toxikol       Date:  1955

6.  [Cholestatic hepatosis following toxogonin treatment in a clinical case of alkylphosphate poisoning].

Authors:  D Klemm; G Blümchen; P Pfannenstiel; W Vogel; K Beck
Journal:  Med Klin       Date:  1968-01-19

7.  [Limits of therapy with oximes in poisoning with insecticidal alkylphosphates].

Authors:  R Zech; W D Erdmann; H Engelhard
Journal:  Arzneimittelforschung       Date:  1967-09

8.  [Effect of E 605 poisoning and specific antidote therapy on the liver function of rabbits].

Authors:  G Boelcke; W D Erdmann
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1969

9.  [On the question of liver damage by E 605 poisoning].

Authors:  H Gros
Journal:  Med Welt       Date:  1965-07-03

10.  [Treatment of parathion (E 605) poisoning with the cholinesterase-reactivating substance obidoxime (Toxogonin)].

Authors:  D Barckow; G Neuhaus; W D Erdmann
Journal:  Arch Toxikol       Date:  1969
  10 in total
  15 in total

1.  [Forensic, clinical, toxicological and legal aspects in a case of survived criminal poisoning with E 605 forte (author's transl)].

Authors:  M Smerling
Journal:  Z Rechtsmed       Date:  1976-02-25

2.  Therapeutic effects of HS-3, HS-6, benactyzine, and atropine in soman poisoning of dogs.

Authors:  J Schenk; W Löffler; N Weger
Journal:  Arch Toxicol       Date:  1976-09-15       Impact factor: 5.153

3.  Improved treatment of organophosphate intoxication by use of scopolamine or dexetimide.

Authors:  U Bertram; A Kasten; H Lüllmann; A Ziegler
Journal:  Experientia       Date:  1977-09-15

4.  Some observations on severe human poisonings with organophosphate pesticides.

Authors:  J Willems; P Vermeire; G Rolly
Journal:  Arch Toxikol       Date:  1971

5.  [Severe percutaneous poisoning with parathion (E 605)].

Authors:  H J Prinz
Journal:  Arch Toxikol       Date:  1969

6.  [Suicidal poisoning by subcutaneous injection of a mixture of parathion and demeton-o-methyl sulfoxide (E 605 MR)].

Authors:  J Knolle
Journal:  Arch Toxikol       Date:  1970

7.  [Clinical significance of determination of cholinesterase in blood in acute poisoning with phosphoorganic insecticides. Retrospective analysis of 37 cases of poisoning].

Authors:  J Knolle
Journal:  Klin Wochenschr       Date:  1970-10-01

8.  Effects of obidoxime chloride on native and sarin-poisoned frog neuromuscular junctions.

Authors:  C G Caratsch; P G Waser
Journal:  Pflugers Arch       Date:  1984-05       Impact factor: 3.657

Review 9.  Cholinesterase inhibition by organophosphorus compounds and its clinical effects.

Authors:  T Namba
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

10.  Probable progress in the therapy of organophosphate poisoning: extracorporeal hemodialysis and hemoperfusion.

Authors:  S Okonek
Journal:  Arch Toxicol       Date:  1976-06-08       Impact factor: 5.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.